Insider Trading

MRVI Stock  USD 5.58  0.19  3.29%   
Under 55% of Maravai Lifesciences' investor base is interested to short. The analysis of overall sentiment of trading Maravai Lifesciences Holdings stock suggests that many investors are impartial at this time. Maravai Lifesciences' investing sentiment shows overall attitude of investors towards Maravai Lifesciences Holdings.
  
Filed transaction by Maravai Lifesciences Holdings Director: . Insider Public Trading

Read at investing.com
Investing News at Macroaxis
  
Maravai insider trading alert for general transaction of by Eckert R Andrew, Director: , on 5th of December 2024. This event was filed by Maravai Lifesciences Holdings with SEC on 2024-12-05. Initial filing of beneficial ownership - SEC Form 3

Maravai Lifesciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Maravai Lifesciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Maravai Lifesciences Fundamental Analysis

We analyze Maravai Lifesciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maravai Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maravai Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

Maravai Lifesciences is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Maravai Lifesciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Maravai Lifesciences stock to make a market-neutral strategy. Peer analysis of Maravai Lifesciences could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics with similar companies.

Peers

Maravai Lifesciences Related Equities

ARQTArcutis Biotherapeutics   5.88   
0%
69.0%
PTGXProtagonist Therapeutics   1.51   
0%
17.0%
APLSApellis Pharmaceuticals   0.18   
0%
2.0%
ASNDAscendis Pharma   0.07   
0%
1.0%
HALOHalozyme Therapeutics   0.06   
0%
1.0%
AGIOAgios Pharm   0.39   
4.0%
0%
ARGXArgenx NV   0.41   
4.0%
0%
EWTXEdgewise Therapeutics   0.43   
5.0%
0%
CYTKCytokinetics   0.91   
10.0%
0%
LEGNLegend Biotech   0.98   
11.0%
0%
HRMYHarmony Biosciences   1.33   
15.0%
0%
ROIVRoivant Sciences   1.90   
22.0%
0%
RAREUltragenyx   2.15   
25.0%
0%
ABUSArbutus Biopharma   2.20   
25.0%
0%
INCYIncyte   2.29   
26.0%
0%
AKROAkero Therapeutics   2.55   
30.0%
0%
DNLIDenali Therapeutics   2.85   
33.0%
0%
INSMInsmed   2.90   
34.0%
0%
IMVTImmunovant   4.50   
53.0%
0%
KRYSKrystal Biotech   5.07   
59.0%
0%
FOLDAmicus Therapeutics   7.39   
87.0%
0%
ALECAlector   8.49   
100.0%
0%

Complementary Tools for Maravai Stock analysis

When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk